FIB-4 cut-off should be re-evaluated in patients with metabolic associated fatty liver disease (MAFLD)

被引：9
|
作者：
Wu, Yinlian
Kumar, Rahul
Huang, Jiaofeng
Wang, Mingfang
Zhu, Yueyong
Lin, Su
机构：
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 74卷 / 01期
关键词：
Metabolic associated fatty liver disease; Nonalcoholic fatty liver disease; FIB-4;
D O I：
10.1016/j.jhep.2020.06.040
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：247 / 248
页数：3
相关论文
共 50 条
  • [21] Effects of sodium glucose cotransporter 2 inhibitors and pioglitazone on FIB-4 index in metabolic-associated fatty liver disease
    Mino, Masaaki
    Kakazu, Eiji
    Sano, Akitoshi
    Katsuyama, Hisayuki
    Hakoshima, Mariko
    Yanai, Hidekatsu
    Aoki, Yoshihiko
    Imamura, Masatoshi
    Yamazoe, Taiji
    Mori, Taizo
    Yoshio, Sachiyo
    Inoue, Jun
    Masamune, Atsushi
    Kanto, Tatsuya
    HEPATOLOGY RESEARCH, 2023, 53 (07) : 618 - 628
  • [22] Nomenclature Dilemma of Metabolic Associated Fatty Liver Disease (MAFLD): Considerable Proportions of MAFLD Are Metabolic Healthy
    Park, Huiyul
    Yoon, Eileen L.
    Kim, Mimi
    Cho, Seon
    Nah, Eun-Hee
    Jun, Dae Won
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (04) : 1041 - +
  • [23] FIB-4 as a screening and disease monitoring method in pre-fibrotic stages of metabolic dysfunction-associated fatty liver disease (MASLD)
    Albert, Stewart G.
    Wood, Emily M.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2024, 38 (07)
  • [24] THE ALCOHOLIC LIVER DISEASE/ NONALCOHOLIC FATTY LIVER DISEASE INDEX ( ANI) IN CLASSIFICATION OF PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE ( MAFLD)
    Roy, Akash
    Goenka, Usha
    Jajodia, Surabhi
    Tewari, Awanish
    Verma, Nipun
    Goenka, Mahesh
    HEPATOLOGY, 2023, 78 : S884 - S885
  • [25] Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD)
    Guo, Qin
    Li, Yun
    Dai, Xin
    Wang, Bangmao
    Zhang, Jie
    Cao, Hailong
    NUTRIENTS, 2023, 15 (17)
  • [26] Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)
    Subramanian, Pallavi
    Hampe, Jochen
    Tacke, Frank
    Chavakis, Triantafyllos
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [27] Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
    Bhopale, Kamlesh K.
    Srinivasan, Mukund P.
    LIVERS, 2023, 3 (04): : 597 - 617
  • [28] FIB-4 Index and Diabetes Mellitus Are Associated with Chronic Kidney Disease in Japanese Patients with Non-Alcoholic Fatty Liver Disease
    Seko, Yuya
    Yano, Kohta
    Takahashi, Aya
    Okishio, Shinya
    Kataoka, Seita
    Okuda, Keiichiroh
    Mizuno, Naoki
    Takemura, Masashi
    Taketani, Hiroyoshi
    Umemura, Atsushi
    Nishikawa, Taichiro
    Yamaguchi, Kanji
    Moriguchi, Michihisa
    Okanoue, Takeshi
    Itoh, Yoshito
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
  • [29] SKIN AUTOFLUORESCENCE IS ASSOCIATED WITH FIB-4, FORNS AND FATTY LIVER INDEX - THE MAASTRICHT STUDY
    Heyens, Leen
    Kenjic, Hanna
    Dagnelie, Pieter
    Schalkwijk, Casper
    Stehouwer, Coen
    Meex, Steven
    Kooman, Jeroen
    Bekers, Otto
    Van Greevenbroek, Marleen
    Savelberg, Hans
    De Galan, Bastiaan
    Koster, Annemarie
    Van Dongen, Martinus
    Eussen, Simone
    Koek, Ger H.
    HEPATOLOGY, 2023, 78 : S882 - S882
  • [30] The Accuracy and Reliability of AST to Platelet Ratio Index, FIB-4, FIB-5, and NAFLD Fibrosis Scores in Detecting Advanced Fibrosis in Patients With Metabolic-Associated Fatty Liver Disease
    Mokhtare, Marjan
    Sadeghian, Amir M.
    Sotoudeheian, Mohammadjavad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1064 - S1065
12345